LBG
BIIB icon

Lloyds Banking Group’s Biogen BIIB Stock Holding History

Lloyds Banking Group’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-3,201
Closed -$1.06M – 104
2014
Q3 		$1.06M Sell
3,201
-561
-15% -$185K 0.29% 92
2014
Q2 		$1.19M Sell
3,762
-76,287
-95% -$23M 0.29% 100
2014
Q1 		$24.5M Buy
80,049
+24,609
+44% +$7.81M 0.22% 132
2013
Q4 		$15.5M Buy
55,440
+3,507
+7% +$907K 0.14% 174
2013
Q3 		$12.5M Buy
51,933
+6,714
+15% +$1.5M 0.13% 179
2013
Q2 		$9.73M Buy
+45,219
New +$9.66M 0.1% 191

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Lloyds Banking Group's BIIB Position: Q4 2014 in Review

Lloyds Banking Group sold out of Biogen (BIIB) in Q4 2014, closing a stake of 3,201 shares — an estimated $1.06M sold.

Lloyds Banking Group first reported a position in BIIB in Q2 2013 and held it in 6 quarters. The position peaked at $24.5M in Q1 2014. 884 funds tracked by Wall St. Rank hold BIIB as of Q4 2014.

  • Lloyds Banking Group reported no remaining Biogen position as of Q4 2014 after selling out during the quarter.
  • Lloyds Banking Group sold 3,201 Biogen shares in Q4 2014, an estimated $1.06M.
  • Lloyds Banking Group first reported a position in Biogen in Q2 2013 and held it in 6 quarters.
  • Lloyds Banking Group's Biogen position peaked at $24.5M in Q1 2014.
  • 884 funds tracked by Wall St. Rank held Biogen as of Q4 2014.

Based on Lloyds Banking Group's 13F filing for Q4 2014, filed 12 Feb 2015.